Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2024 ASH Annual Meeting
2024 San Antonio Breast Cancer Symposium
RSNA 2024 Annual Meeting
2024 JADPRO Live
Quantitative Imaging Workshop XXI
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
NCCN Oncology Policy Summit,NCCN Oncology Policy Summit
«
1
»
Advertisement
Advertisement
Dec
11
Today In Oncology
Rilzabrutinib Found Safe and Effective for Refractory Immune Thrombocytopenia
Lower Socioeconomic Status Impacts AML Patients’ Ability to Receive Hematopoietic Cell Transplantation
Common Bacterial Toxin May Speed Up Colorectal Cancer Metastasis
Loncastuximab Tesirine May Improve Outcomes in High Risk Follicular Lymphoma Marginal Zone Lymphoma
Study Finds Daratumumab Monotherapy Prevented or Delayed Progression From Smoldering to Active Multiple Myeloma
View More
Advertisement
